SW
Stephen Willey Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$31B
| $146.59 | $145 |
1%
downside
| Buy | 20 days ago |
|
2
AbCellera Biologics
ABCL
$1.25B
| $4.19 | $7 |
67%
upside
| Buy | 26 days ago |
|
3
Exelixis
EXEL
$10B
| $37.31 | $41 |
10%
upside
| Hold | 1 month ago |
|
4
Celcuity
CELC
$2.28B
| $53.84 | $30 |
44%
downside
| Buy | 2 months ago |
|
5
Incyte
INCY
$17B
| $87.23 | $107 |
23%
upside
| Buy | 2 months ago |
|
6
Nurix Therapeutics
NRIX
$719M
| $9.41 | $35 |
272%
upside
| Buy | 4 months ago |
|
7
Vor Biopharma
VOR
$264M
| $2.08 | $5 |
140%
upside
| Buy | 5 months ago |
|
8
Geron
GERN
$938M
| $1.47 | $4 |
172%
upside
| Buy | 6 months ago |
|
9
Zymeworks
ZYME
$1.07B
| $14.12 | $28 |
98%
upside
| Buy | 10 months ago |
|
|
BCAX
10
Bicara Therapeutics Inc. Common Stock
BCAX
$654M
| $11.99 | $47 |
292%
upside
| Buy | 11 months ago |
|
11
Xenon Pharmaceuticals
XENE
$3.05B
| $39.56 | $62 |
57%
upside
| Buy | 1 year ago |
|
|
12
Vor Biopharma
VOR
$264M
| $2.08 | $16 |
669%
upside
| Buy | 2 years ago |
|
13
Compass Therapeutics
CMPX
$478M
| $3.46 | $9 |
160%
upside
| Buy | 2 years ago |
|